AI-driven drug discovery is accelerating innovation and transforming biopharma R&D.
AI-driven drug discovery is accelerating innovation and transforming biopharma R&D.
Australia’s National Genomic Registry is connecting patients, clinicians, and researchers to transform rare disease care in real time.
Australian-led clinical trials are advancing the future of diabetes care with oral insulin innovations.
New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
New device approval and robust oncology funding highlight ongoing biopharma momentum in cancer therapies.
A promising vaccine candidate advances efforts to combat neglected tropical diseases with mRNA innovation.
Partnership targets Alzheimer’s and Parkinson’s with novel delivery platforms and precision medicine approaches.
Despite economic caution, pharma and biotech leaders invest boldly to reshape pipelines and accelerate innovation.
Next-generation gene editing powers new hope for hard-to-treat solid tumors in early human trials.
A pivotal step forward for Duchenne families as gene therapy shows promise to transform neuromuscular care.
Already a subscriber? Log in